首页>Biochemical and Biophysical Research Communications>Low dose CP-690,550 (tofacitinib), a pan-JAK inhibitor, accelerates the onset of experimental autoimmune encephalomyelitis by potentiating Th17 differentiation
Low dose CP-690,550 (tofacitinib), a pan-JAK inhibitor, accelerates the onset of experimental autoimmune encephalomyelitis by potentiating Th17 differentiation
作者单位：Department of Pulmonary Medicine, Graduate School of Medical and Dental Sciences, Kagoshima[1]Department of Microbiology and Immunology, Keio University School of Medicine, Shinjuku-ku, Tokyo[2]
换一批
换一批
